LGALS13 antibody (AA 51-100)
Quick Overview for LGALS13 antibody (AA 51-100) (ABIN6745552)
Target
See all LGALS13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 51-100
-
Specificity
- Human LGALS13 / Galectin 3
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa51-100 of human LGALS13 (Q9UHV8, NP_037400). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey (100%), Chimpanzee (92%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- LGALS13 (Lectin, Galactoside-Binding, Soluble, 13 (LGALS13))
-
Alternative Name
- LGALS13 / Galectin 13
-
Background
-
Name/Gene ID: LGALS13
Synonyms: LGALS13, Gal-13, GAL13, Placental protein 13, Placental tissue protein 13, Galectin 13, Galectin-13, PP13 -
Gene ID
- 29124
-
NCBI Accession
- NP_037400
-
UniProt
- Q9UHV8
Target
-